The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets; D002170:Canada; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000601:surgery; D004691:Endarterectomy; D006801:Humans; D002546:Ischemic Attack, Transient; D008297:Male; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D000925:Anticoagulants; D001241:Aspirin; D013442:Sulfinpyrazone